Evidence map›Paper›PMID 25080494›Full record

ArticleMolecular systems biology2014

Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases.

Manikandan Narayanan, Jimmy L Huynh, Kai Wang, Xia Yang, Seungyeul Yoo, Joshua McElwee, Bin Zhang, Chunsheng Zhang, John R Lamb, Tao Xie and 10 more

Open access · goldAbstract read
In one paragraph

Article in Molecular systems biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 5 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 5 syntheses or guidelines pooled it, 205 citations in OpenAlex.

  1. Meta-Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross-Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross-Study Heterogeneity.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Investigation of the Potential Neuroprotective Mechanisms ofInternational journal of molecular sciences · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Decoding Alzheimer's Disease One Cell Class at a Time.Cellular and molecular neurobiology · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Manikandan NarayananNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA manikandan.narayanan@nih.gov jun.zhu@mssm.edu.
Jimmy L HuynhDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kai WangMerck Research Laboratories Merck & Co., Inc., Whitehouse Station, NJ, USA.
Xia YangDepartment of Integrative Biology and Physiology, University of California, Los Angeles, CA, USA.
Seungyeul YooDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Joshua McElweeMerck Research Laboratories Merck & Co., Inc., Whitehouse Station, NJ, USA.
Bin ZhangDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Chunsheng ZhangMerck Research Laboratories Merck & Co., Inc., Whitehouse Station, NJ, USA.
John R LambMerck Research Laboratories Merck & Co., Inc., Whitehouse Station, NJ, USA.
Tao XieMerck Research Laboratories Merck & Co., Inc., Whitehouse Station, NJ, USA.
Christine SuverSage Bionetworks, Seattle, WA, USA.
Cliona MolonyMerck Research Laboratories Merck & Co., Inc., Whitehouse Station, NJ, USA.
Stacey MelquistMerck Research Laboratories Merck & Co., Inc., Whitehouse Station, NJ, USA.
Andrew D JohnsonNational Heart, Lung and Blood Institute, Bethesda, MD, USA.
Guoping FanDepartment of Human Genetics, University of California, Los Angeles, CA, USA.
David J StoneMerck Research Laboratories Merck & Co., Inc., Whitehouse Station, NJ, USA.
Eric E SchadtDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Patrizia CasacciaDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Valur EmilssonIcelandic Heart Association, Kopavogur, Iceland Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
Jun ZhuDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA manikandan.narayanan@nih.gov jun.zhu@mssm.edu.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USIcahn School of Medicine at Mount Sinai · USUniversity of California, Los Angeles · USNational Heart Lung and Blood Institute · USNational Institute of Allergy and Infectious Diseases · USSage Bionetworks · USUniversity of Iceland · IS

Funding

Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's DiseaseU01AG046170 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, MINGHUI, ZHANG, BIN · 2013 to 2022
$26.0M
Cardiovascular Genomics and Bioinformatics projectsZIAHL006170 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI JOHNSON, ANDREW · 2013 to 2025
$25.3M
A Natonal Resource for Postmortem Brain ResearchR24MH068855 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 2003 to 2012
$14.8M
Histone Deacetylation in Oligodendrocyte DifferentiationR37NS042925 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CASACCIA, PATRIZIA · 2012 to 2018
$4.3M
Epistatic and Cross Tissue Analysis for Human Gene Expression TraitsR01MH090948 · NIMH · HARVARD UNIVERSITY · PI LIU, JUN S · 2010 to 2011
$588k
Evolution of cancer-specific molecular requirements for glioblastoma multiforme (R21CA170722 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PADDISON, PATRICK, ZHU, JUN · 2012 to 2013
$418k
DNA methylation is necessary for the acquisition of an oligodendrocyte identityF31NS077504 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HUYNH, JIMMY · 2011 to 2013
$141k
Intramural NIH HHSNCI NIH HHS R21 CA170722NIA NIH HHS R01AG046170NIA NIH HHS U01 AG046170NIMH NIH HHS R01 MH090948NIMH NIH HHS R01MH090948-01NIMH NIH HHS R24 MH068855NINDS NIH HHS F31 NS077504NINDS NIH HHS F31NS077504NINDS NIH HHS R37 NS042925NINDS NIH HHS R37NS042925-10
6 · The paper itself

Abstract

Using expression profiles from postmortem prefrontal cortex samples of 624 dementia patients and non-demented controls, we investigated global disruptions in the co-regulation of genes in two neurodegenerative diseases, late-onset Alzheimer's disease (AD) and Huntington's disease (HD). We identified networks of differentially co-expressed (DC) gene pairs that either gained or lost correlation in disease cases relative to the control group, with the former dominant for both AD and HD and both patterns replicating in independent human cohorts of AD and aging. When aligning networks of DC patterns and physical interactions, we identified a 242-gene subnetwork enriched for independent AD/HD signatures. This subnetwork revealed a surprising dichotomy of gained/lost correlations among two inter-connected processes, chromatin organization and neural differentiation, and included DNA methyltransferases, DNMT1 and DNMT3A, of which we predicted the former but not latter as a key regulator. To validate the inter-connection of these two processes and our key regulator prediction, we generated two brain-specific knockout (KO) mice and show that Dnmt1 KO signature significantly overlaps with the subnetwork (P = 3.1 × 10(-12)), while Dnmt3a KO signature does not (P = 0.017).

Indexed as

Gene Regulatory NetworksAlzheimer DiseaseAnimalsAutopsyCase-Control StudiesChromatinDementiaDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AGene Expression ProfilingGene Expression RegulationHumansHuntington DiseaseMiceMice, KnockoutChromatinDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNMT1 protein, humanDnmt1 protein, mouseDNMT3A protein, humanDnmt3a protein, mousedifferential co‐expressiondysregulatory gene networksepigenetic regulation of neural differentiationnetwork alignmentneurodegenerative diseases

Identifiers

PMID25080494
PMCPMC4299500
OpenAlexW2111219940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.